ZA722560B - 6-phenyl-s-triazolo(4,3-a)(1,4)-benzodiazepines - Google Patents

6-phenyl-s-triazolo(4,3-a)(1,4)-benzodiazepines

Info

Publication number
ZA722560B
ZA722560B ZA722560A ZA722560A ZA722560B ZA 722560 B ZA722560 B ZA 722560B ZA 722560 A ZA722560 A ZA 722560A ZA 722560 A ZA722560 A ZA 722560A ZA 722560 B ZA722560 B ZA 722560B
Authority
ZA
South Africa
Prior art keywords
benzodiazepines
triazolo
phenyl
Prior art date
Application number
ZA722560A
Other languages
English (en)
Inventor
J Hester
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of ZA722560B publication Critical patent/ZA722560B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA722560A 1971-05-11 1972-04-17 6-phenyl-s-triazolo(4,3-a)(1,4)-benzodiazepines ZA722560B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14241871A 1971-05-11 1971-05-11

Publications (1)

Publication Number Publication Date
ZA722560B true ZA722560B (en) 1973-02-28

Family

ID=22499766

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA722560A ZA722560B (en) 1971-05-11 1972-04-17 6-phenyl-s-triazolo(4,3-a)(1,4)-benzodiazepines

Country Status (9)

Country Link
US (2) US3681343A (enExample)
AU (1) AU472686B2 (enExample)
BE (1) BE783273A (enExample)
CH (3) CH573942A5 (enExample)
DE (1) DE2221790A1 (enExample)
FR (1) FR2137713B1 (enExample)
GB (2) GB1380880A (enExample)
NL (1) NL7206302A (enExample)
ZA (1) ZA722560B (enExample)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2156472A1 (de) 1970-11-23 1972-05-31 Ciba-Geigy Ag, Basel (Schweiz) Verfahren zur Herstellung von neuen Diazepinderivaten
JPS4932874B1 (enExample) * 1970-12-11 1974-09-03
CH545302A (de) * 1971-04-08 1974-01-13 Ciba Geigy Ag Verfahren zur Herstellung von neuen Triazolo-benzodiazepinderivaten
US3946032A (en) * 1971-04-08 1976-03-23 Ciba-Geigy Corporation Acetal derivatives of 6-phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepine-1-carboxaldehyde
US4250094A (en) * 1971-04-28 1981-02-10 The Upjohn Company 1-(Aminoalkyl) substituted-6-phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepines
US4902794A (en) * 1971-04-28 1990-02-20 The Upjohn Company Triazolo-benzodiazepines
DE2308280A1 (de) * 1971-11-15 1973-09-06 Ciba Geigy Ag Verfahren zur herstellung von neuen diazepinderivaten
US3886174A (en) * 1971-11-22 1975-05-27 Upjohn Co 1-Substituted-6-phenyl-4H-s-triazolo{8 4,3-a{9 {8 1,4{9 benzodiazepines
CH567031A5 (enExample) * 1972-05-18 1975-09-30 Ciba Geigy Ag
US3879406A (en) * 1972-07-13 1975-04-22 Hoffmann La Roche Preparation of triazolobenzodiazepines
IE38931B1 (en) * 1973-03-09 1978-07-05 Lipha Triazolobenzodiazepines
US4213982A (en) 1973-05-29 1980-07-22 E. R. Squibb & Sons, Inc. Novel 4H-S-triazolo[4,3-A] [1,5]benzodiazepin-5-ones
IE41197B1 (en) 1973-05-29 1979-11-07 Squibb & Sons Inc 4h-s-triazolo (4,3-a)(1,5)benzodiazepin-5-ones
AT338799B (de) * 1974-03-02 1977-09-12 Boehringer Sohn Ingelheim Verfahren zur herstellung neuer substituierter 6-aryl-4h-s-triazolo-(3,4c)-thieno-(2,3e)-1,4-diazepine und ihrer salze
JPS5747914B2 (enExample) * 1974-04-12 1982-10-13
US3910944A (en) * 1974-11-20 1975-10-07 Upjohn Co Spiro(cyclopropane-1,4{40 -(4H)-s-triazolo-(4,3-a)(1,4)benzodiazepines)
US4044016A (en) * 1975-01-13 1977-08-23 Hoffmann-La Roche Inc. Preparation of triazolo benzodiazepines and novel compounds
US4018788A (en) * 1975-06-16 1977-04-19 The Upjohn Company 6-(O-Halophenyl)-1-methyl-4H-s-triazolo[4,3-a][1,4]-benzodiazepine
US4226772A (en) * 1976-03-15 1980-10-07 The Upjohn Company 1-[(Dialkylamino)methyl]-6-phenyl-4H-s-[4,3,-a][1,4]triazolobenzodiazepine N1 -oxide
US4009175A (en) * 1976-03-15 1977-02-22 The Upjohn Company 1-[(Aminooxy)-methyl]-6-substituted-4H-s-triazolo[4,3-a][1,4] benzodiazepines
US4415583A (en) * 1980-03-27 1983-11-15 The Upjohn Company Process for inducing hypnosis
US4374842A (en) * 1980-04-18 1983-02-22 Shionogi & Co., Ltd. 4,1-Benzoxazepines and compositions
US4479959A (en) * 1981-01-29 1984-10-30 The Upjohn Company Process for inducing hypnosis
US4444781A (en) * 1981-04-06 1984-04-24 The Upjohn Company Process for inducing hypnosis
CA2799381A1 (en) 2010-05-14 2011-11-17 Dana-Farber Cancer Institute, Inc. Male contraceptive compositions and methods of use
AU2015201727B2 (en) * 2010-05-14 2018-03-08 Dana-Farber Cancer Institute, Inc. Compositions and methods for treating neoplasia, inflammatory disease and other disorders
MX373121B (es) 2010-05-14 2020-04-30 Dana Farber Cancer Inst Inc Composiciones y metodos para el tratamiento de leucemia.
US8981083B2 (en) * 2010-05-14 2015-03-17 Dana Farber Cancer Institute, Inc. Compositions and methods for treating neoplasia, inflammatory disease and other disorders
US9249161B2 (en) 2010-12-02 2016-02-02 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
AR084070A1 (es) 2010-12-02 2013-04-17 Constellation Pharmaceuticals Inc Inhibidores del bromodominio y usos de los mismos
WO2012151512A2 (en) 2011-05-04 2012-11-08 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
US9328117B2 (en) 2011-06-17 2016-05-03 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
TWI602820B (zh) 2012-06-06 2017-10-21 星宿藥物公司 溴域抑制劑及其用途
US9624244B2 (en) 2012-06-06 2017-04-18 Constellation Pharmaceuticals, Inc. Benzo [B] isoxazoloazepine bromodomain inhibitors and uses thereof
BR112016001457A2 (pt) 2013-07-25 2017-08-29 Dana Farber Cancer Inst Inc Inibidores de fatores de transcrição e usos dos mesmos
KR20160072261A (ko) 2013-11-08 2016-06-22 다나-파버 캔서 인스티튜트 인크. 브로모도메인 및 엑스트라-말단 (bet) 단백질 저해제를 이용한 암 치료를 위한 조합 요법
MX2016009974A (es) 2014-01-31 2016-10-31 Dana Farber Cancer Inst Inc Derivados de diaminopirimidina bencensulfona y sus usos.
WO2015117087A1 (en) 2014-01-31 2015-08-06 Dana-Farber Cancer Institute, Inc. Uses of diazepane derivatives
RU2722179C2 (ru) 2014-02-28 2020-05-28 Тэнша Терапеутикс, Инк. Лечение состояний, ассоциированных с гиперинсулинемией
CN106687463B (zh) 2014-06-20 2019-04-09 星座制药公司 一种乙酰胺类化合物的晶型
EP3177626A4 (en) 2014-08-08 2017-12-27 Dana Farber Cancer Institute, Inc. Diazepane derivatives and uses thereof
WO2016022970A1 (en) 2014-08-08 2016-02-11 Dana-Farber Cancer Institute, Inc. Dihydropteridinone derivatives and uses thereof
UA122130C2 (uk) 2014-10-27 2020-09-25 Тенша Терапеутікс, Інк. Інгібітори бромодомену
US10702527B2 (en) 2015-06-12 2020-07-07 Dana-Farber Cancer Institute, Inc. Combination therapy of transcription inhibitors and kinase inhibitors
US11306105B2 (en) 2015-09-11 2022-04-19 Dana-Farber Cancer Institute, Inc. Cyano thienotriazolodiazepines and uses thereof
JP2018526424A (ja) 2015-09-11 2018-09-13 ダナ−ファーバー キャンサー インスティテュート， インコーポレイテッド アセトアミドチエノトリアゾロジアゼピンおよびこれらの使用
CR20180336A (es) 2015-11-25 2018-08-06 Dana Farber Cancer Inst Inc Inhibidores de bromodominio bivalentes y usos de los mismos
US11472806B2 (en) 2017-05-12 2022-10-18 Domain Therapeutics Substituted heterocyclic compounds as allosteric modulators of group II metabotropic glutamate receptors
PE20230440A1 (es) 2020-03-31 2023-03-08 Hoffmann La Roche Derivados de benzodiazepinas como pam de gaba a gamma1
WO2023052312A1 (en) 2021-09-29 2023-04-06 F. Hoffmann-La Roche Ag New benzodiazepine derivatives as gaba a gamma1 pam
EP4426683A1 (en) 2021-10-06 2024-09-11 F. Hoffmann-La Roche AG Benzodiazepine derivatives as positive allosteric modulators of the gaba a gamma1 receptor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH540247A (de) * 1967-04-21 1973-09-28 Ciba Geigy Ag Verfahren zur Herstellung von heterocyclischen, Asthylendoppelbindungen enthaltenden Verbindungen
JPS4837280B1 (enExample) * 1969-03-08 1973-11-09
YU34997B (en) * 1970-03-27 1980-06-30 Hiroyuki Tawada Process for preparing benzodiazepine derivatives

Also Published As

Publication number Publication date
GB1380880A (en) 1975-01-15
GB1377435A (en) 1974-12-18
CH573942A5 (enExample) 1976-03-31
CH572485A5 (enExample) 1976-02-13
AU472686B2 (en) 1976-06-03
NL7206302A (enExample) 1972-11-14
USRE28505E (en) 1975-08-05
US3681343A (en) 1972-08-01
CH582180A5 (enExample) 1976-11-30
DE2221790A1 (de) 1972-11-23
FR2137713B1 (enExample) 1975-12-26
BE783273A (fr) 1972-11-10
FR2137713A1 (enExample) 1972-12-29
AU4164072A (en) 1973-11-01

Similar Documents

Publication Publication Date Title
ZA722560B (en) 6-phenyl-s-triazolo(4,3-a)(1,4)-benzodiazepines
PH9329A (en) 6-phenyl-1-substituted-4h-s-triazolo(4,3-a)-benzodiazepines
CA962666A (en) 1,25-dihydroxycholecaliferol
ZA722627B (en) 4h-5-triazolo(4,3-a)(1,4)benzodiazepines
ZA722261B (en) 1-substituted-6-phenyl-4h-s-triazolo(4,3-a)(1,4)-benzo-diazepines and process
CA988092A (en) 4,5-dihalopyrrole-2-carbonitriles
IL38936A (en) 1,6-dimethyl-10alpha-methoxy-8beta-pyrroyloxymethyl-ergolines
ZA727046B (en) 1,4-bis-acypiperazines
CA997763A (en) 2,4,diamino-5-benzylpyrimidine
AU468410B2 (en) 2, 4-diamino-5-benzyl-pyrimidines
ZA723636B (en) 1,6-disubstituted-4h-s-triazolo(4,3-a)(1,4)-benzodiazepines
GB1407798A (en) Substituted 1,2,5-triazoles
PH9908A (en) 2,9-dihydro-3h-dibenzo(c,f)-s-triazolo(4,3-a)-azepin-3-ones
AU4117472A (en) 2, 4-diamino-5-benzyl-pyrimidines
ZA722183B (en) 1,2-biguanides
CA975378A (en) 5-hydoxymethyl-(1,3-dioxa-2-silacyclohexanes)
CA976543A (en) 4,6,8(14)-triene-steroids
ZA725040B (en) 1-r1-2-(3,4-dialkoxy-beta-or2-beta-phenethyl)iminopyrrolidines
ZA724939B (en) Ideno(1,2,-a)idenealkylamines
IL38791A0 (en) 2,3-benzoxazepine derivatives
ZA722258B (en) 1-substituted-6-phenyl-4h-s-triazolo(4,3-a)(1,4)-benzodiazepines and process
ZA722257B (en) 1-substituted-6-phenyl-4h-s-triazolo(4,3-a)(1,4)-benzodiazepines and process
CA880323A (en) Hexahydro-and octahydro-1,12-trimethyleneindolo (2,3-a) quinolizines
CA882143A (en) 3,4-epoxy-4-methylcyclohexanes
CA871704A (en) 2,6-methano-3-benzazocines